Study recommends coverage of lung cancer screening


"These results demonstrate the cost efficiency of offering this benefit to people who are at high risk of lung cancer," lead author Bruce Pyenson said in a statement. "The evidence of the value of advanced screening technology for lung cancer has accumulated to the point where we can show very strong cost-effectiveness for the commercial population. We can also jump the needle on cancer mortality for the first time in years, and do so in a cost-effective manner."

The results confirm research by the National Cancer Institute, which last year published results showing that screening with computed tomography — CT scans — can reduce the risk of dying from lung cancer.